Novel Delivery Systems for Nicotine Replacement Therapy as an Aid to Smoking Cessation and for Harm Reduction: Rationale, and Evidence for Advantages over Existing Systems Lion ShahabLeonie S. BroseRobert West Leading Article 11 October 2013 Pages: 1007 - 1019
Clinically Significant Drug Interactions with Atypical Antipsychotics William Klugh KennedyMichael W. JannEric C. Kutscher Review Article 30 October 2013 Pages: 1021 - 1048
Animal Migraine Models for Drug Development: Status and Future Perspectives Inger Jansen-OlesenPeer Tfelt-HansenJes Olesen Review Article 14 November 2013 Pages: 1049 - 1068
Second Generation Antipsychotic-Induced Type 2 Diabetes: A Role for the Muscarinic M3 Receptor Katrina Weston-GreenXu-Feng HuangChao Deng Review Article 10 October 2013 Pages: 1069 - 1080
Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study Ralf W. DittmannEsther CardoDavid Coghill Original Research Article Open access 20 August 2013 Pages: 1081 - 1092
Scopolamine Detoxification Technique for Heroin Dependence: A Randomized Trial Sheng LiuLonghui LiWenhua Zhou Original Research Article 03 October 2013 Pages: 1093 - 1102
Teriflunomide: A Review of Its Use in Relapsing Multiple Sclerosis Karly P. Garnock-Jones Adis Drug Evaluation 07 November 2013 Pages: 1103 - 1123
Lacosamide: A Review of Its Use as Adjunctive Therapy in the Management of Partial-Onset Seizures Sheridan M. Hoy Adis Drug Evaluation 08 November 2013 Pages: 1125 - 1142
Erratum to: Systematic Review and Meta-Analysis of the Efficacy and Safety of Perampanel in the Treatment of Partial-Onset Epilepsy Warrington W. Q. HsuC. W. SingEsther W. Chan Erratum 14 November 2013 Pages: 1143 - 1143